AR228444A1 - Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales - Google Patents

Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales

Info

Publication number
AR228444A1
AR228444A1 AR283833A AR28383380A AR228444A1 AR 228444 A1 AR228444 A1 AR 228444A1 AR 283833 A AR283833 A AR 283833A AR 28383380 A AR28383380 A AR 28383380A AR 228444 A1 AR228444 A1 AR 228444A1
Authority
AR
Argentina
Prior art keywords
tiazolidin
bencil
diona
salts
procedure
Prior art date
Application number
AR283833A
Other languages
English (en)
Spanish (es)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of AR228444A1 publication Critical patent/AR228444A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AR283833A 1980-01-07 1980-12-30 Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales AR228444A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP76280A JPS5697277A (en) 1980-01-07 1980-01-07 Thiazolidine derivative

Publications (1)

Publication Number Publication Date
AR228444A1 true AR228444A1 (es) 1983-03-15

Family

ID=11482698

Family Applications (1)

Application Number Title Priority Date Filing Date
AR283833A AR228444A1 (es) 1980-01-07 1980-12-30 Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales

Country Status (6)

Country Link
US (1) US4376777A (ja)
EP (1) EP0032128A1 (ja)
JP (1) JPS5697277A (ja)
AR (1) AR228444A1 (ja)
DK (1) DK2281A (ja)
ES (1) ES8202546A1 (ja)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118577A (ja) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd チアゾリジン誘導体
JPS58177983A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd チアゾリジン誘導体
WO1986002073A1 (en) * 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
CA1285572C (en) * 1985-08-09 1991-07-02 Jill Ann Panetta Di-t-butylphenol compounds
US5260445A (en) * 1987-09-04 1993-11-09 Beecham Group P.L.C. 2,4-thiazolidinediones
JPH01180102U (ja) * 1988-06-02 1989-12-25
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
WO1991017151A1 (en) * 1990-04-27 1991-11-14 Orion-Yhtymä Oy New pharmacologically active catechol derivatives
JPH0463570U (ja) * 1990-10-09 1992-05-29
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
JPH066904A (ja) * 1991-03-01 1994-01-14 Hitachi Kiden Kogyo Ltd クリーンルーム用無人搬送車の無人給電装置
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
DE69838789T2 (de) * 1997-03-12 2008-10-30 Suzanne Cambridge de la Monte Verfahren zur behandlung oder prävention der alzheimerischen krankheit
PL198018B1 (pl) * 1997-06-18 2008-05-30 Smithkline Beecham Plc Kompozycja farmaceutyczna przeciwcukrzycowa zawierająca sulfonylomocznik i tiazolidynodion i jej zastosowanie
JP2002504137A (ja) * 1997-06-18 2002-02-05 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー チアゾリジンジオンおよびメトホルミンを用いる糖尿病の治療
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
US7105552B2 (en) 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
CZ20011629A3 (cs) 1998-11-12 2001-12-12 Smithkline Beecham Plc Farmaceutický prostředek pro upravené uvolňování senzitizéru inzulínu a jiných antidiabetických přípravků
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US7407978B2 (en) 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
KR20010099634A (ko) * 1999-07-01 2001-11-09 할리 켈빈 비. 텔로머라제 저해제 및 그 사용 방법
JP2001072592A (ja) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd テロメラーゼ阻害剤
US6958355B2 (en) * 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6784199B2 (en) 2000-09-21 2004-08-31 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20060047000A1 (en) * 2001-04-24 2006-03-02 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ATE377855T1 (de) * 2002-01-16 2007-11-15 Gen Electric Instrumententafelmittenstapel mit integrierter verdrahtung
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US20060130903A1 (en) * 2002-11-21 2006-06-22 Frank Whittaker Check valve
WO2005041951A2 (en) * 2003-10-28 2005-05-12 Rigel Pharmaceuticals, Inc. Rhodanine derivatives for use as antiviral agents
AR057324A1 (es) * 2005-05-27 2007-11-28 Wyeth Corp Tigeciclina y metodos para preparar 9-aminominociclina
US7973062B2 (en) * 2008-02-22 2011-07-05 The Ohio State University Research Foundation Androgen receptor-ablative agents
EP2488027A4 (en) 2009-10-09 2013-04-17 Univ Ohio State Res Found THIAZOLIDINDIONENERGIERESTRIKTIONSMIMETIKA
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1284516A (fr) * 1957-11-20 1962-02-16 France Etat Produits utilisables notamment comme agents susceptibles d'agir sur la croissance des plantes et leur procédé de fabrication
NL265085A (ja) * 1960-05-24
US3200126A (en) * 1963-05-31 1965-08-10 Warner Lambert Pharmaceutical 3-alkyl-5-amino-2, 4-thiazolidinediones
US3825553A (en) * 1970-05-05 1974-07-23 Rorer Inc William H Certain 5-arylthiazolidines
SU480711A1 (ru) * 1973-07-02 1975-08-15 Ленинградский Ордена Трудового Красного Знамени Технологический Институт Им.Ленсовета Способ получени производных 3-оксиметилтиазолиндиона-2,4
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative

Also Published As

Publication number Publication date
JPS5697277A (en) 1981-08-05
EP0032128A1 (en) 1981-07-15
DK2281A (da) 1981-07-08
US4376777A (en) 1983-03-15
ES498320A0 (es) 1982-02-01
JPS6310702B2 (ja) 1988-03-08
ES8202546A1 (es) 1982-02-01

Similar Documents

Publication Publication Date Title
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR227556A1 (es) Procedimiento para preparar derivados de 2-fenil-amino-2-imidazolina y sus sales
AR223069A1 (es) Polieterpoliaminas y sus sales,procedimiento para su preparacion y su empleo
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR228851A1 (es) Procedimiento para preparar 9-hidroxi-9-aminoalquilflourenos y sus sales
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR218878A1 (es) Procedimiento para preparar derivados de benzopirano y sus sales
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR231289A1 (es) Procedimiento para preparar derivados de quinolil-4-1-piperidilo-4-2-etanol o quinolil-4-1-piperidil-4-3-propanol
AR228437A1 (es) Procedimiento para preparar compuestos de 6-fenil-2-oxo-nicotinoilamoxicilina y sus sales
ES515568A0 (es) Procedimiento para preparar derivados de fenantreno.
ES515767A0 (es) Procedimiento para preparar derivados de indano.
ES490505A0 (es) Procedimiento de preparacion de nuevos derivados benzo-as- triazinos y de sus sales de adicion acidas, farmaceuticamen-te aceptables
AR228852A1 (es) Procedimiento para preparar derivados de 1,1'bifenil-2-il-alquilamina y sus sales
AR226825A1 (es) Procedimiento para preparar derivados de 2-hidroxi-propilaminoalquil guanidinas y sus sales de adicion
ES504681A0 (es) Procedimiento para preparar derivados de 11- hidroxi-13 oxa-prostaglandina.
AR220561A1 (es) Procedimiento para preparar compuestos de 5,8-dihidro 3,2-b-1,8-naftiridina y sus sales
AR231540A1 (es) Procedimiento para la elaboracion de derivados de 2-oxo-3-n-2,3-dihidro b-tiofeno y sus sales